Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmyocardial laser revascularization

O H Frazier1, K Kadipasaoglu

  • 1Department of Cardiovascular Surgery, Texas Heart Institute, Houston 77225-0345, USA.

Current Opinion in Cardiology
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reconstruction of the fibrous trigone.

Texas Heart Institute journal·2009
Same author

Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support.

European journal of heart failure·2009
Same author

Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2009
Same author

Urgent exchange of a HeartMate II left ventricular assist device after percutaneous lead fracture.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2009
Same author

Use of magnetic resonance imaging to assess myocardial perfusion after transmyocardial laser revascularization.

The heart surgery forum·2009
Same author

Elective tracheotomy facilitates total artificial heart implantation in calves.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2009
Same journal

Contemporary medical management of left ventricular assist device patients: integrating sex-specific perspectives.

Current opinion in cardiology·2026
Same journal

Viability testing for guiding revascularization in ischemic cardiomyopathy.

Current opinion in cardiology·2026
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
See all related articles

Transmyocardial laser revascularization shows promise for relieving angina in patients with ischemic heart conditions. This minimally invasive technique creates channels in the heart muscle, improving symptoms and exercise tolerance.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Procedures
  • Ischemic Heart Disease

Background:

  • Angina pectoris is a common symptom of ischemic myocardium.
  • Current treatments for severe angina may have limitations.
  • Transmyocardial laser revascularization (TMLR) is an emerging alternative therapy.

Purpose of the Study:

  • To evaluate the efficacy and safety of TMLR in patients with refractory angina.
  • To assess the potential of TMLR as an alternative to conventional revascularization methods.

Main Methods:

  • Utilizes an 800-W carbon dioxide laser to create myocardial channels.
  • Channels are opened directly into the left ventricular cavity.
  • Patients with ischemic myocardium undergo the TMLR procedure.

Related Experiment Videos

Main Results:

  • Initial clinical trials indicate significant relief from angina symptoms.
  • Improved exercise tolerance observed in treated patients.
  • The procedure demonstrates minimal complications and established safety.

Conclusions:

  • TMLR appears to be a safe and effective option for angina relief.
  • Further randomized trials are ongoing to confirm these promising initial findings.
  • TMLR may offer a viable alternative for patients with ischemic heart disease.